Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 4th Quarter - Report

PROTHENA BIOSCIENCES INC

via HORIZON GOVERNMENT AFFAIRS

4th Quarter (Oct 1 - Dec 31) · 2018Posted Jan 16, 2019Filing document ↗LDA record ↗

Income$20Kfee reported

Client

Name: PROTHENA BIOSCIENCES INC
Description: Clinical Biotechnology Company
Location: California · United States of America

Registrant

Firm: HORIZON GOVERNMENT AFFAIRS
Description: Health Care and Health Care Coverage
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
21st Century Cures Implementation
LobbyistsJOEL WHITE · JENNIFER BERNSTEIN
Covered position (JOEL WHITE): Former Staff Director, Ways & Means Health Subcommittee
TargetedHOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

PROTHENA BIOSCIENCES INC — Lobbying — Receipts Report